Could Moderna Beat Novavax to Market With a COVID-Flu Vaccine?
30/1 15:27
Combination vaccines could enjoy significant demand if COVID-19 becomes endemic, as many expect. In this Motley Fool Live video recorded on Jan. 19, Motley Fool contributors Keith Speights and Brian Orelli discuss whether Moderna (NASDAQ: MRNA) could beat Novavax (NASDAQ: NVAX) w...